Having regard to Commission Decision 2009/872/EC of 30 November 2009 establishing a European Union Committee of Experts on Rare Diseases(1), and in particular Article 3(4) thereof,
Verify source ↗ AI-assisted research summary: The Commission appoints the experts listed in the Annex as members of the EU Committee on Rare Diseases.
28.7.2010 | EN | Official Journal of the European Union | C 204/2 ---|---|---|--- * * * COMMISSION DECISION of 27 July 2010 on the appointment of the members of the European Union Committee of Experts on Rare Diseases set up by Decision 2009/872/EC 2010/C 204/02 THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Commission Decision 2009/872/EC of 30 November 2009 establishing a European Union Committee of Experts on Rare Diseases (1), and in particular Article 3(4) thereof, Whereas: (1) | According to Article 3(1) of Decision 2009/872/EC, the European Union Committee of Experts on Rare Diseases (hereinafter, ‘the Committee’) shall comprise 51 members and the corresponding alternates. ---|--- (2) | According to Article 3(4) of Decision 2009/872/EC, among these 51 members, the following members shall be appointed by the Commission: four representatives from patients' organisations, four representatives of the pharmaceutical industry, nine representatives of ongoing and/or past Community projects in the field of rare diseases financed by programmes of Community action in the filed of health (2) including three members of the pilot European Reference Networks on rare diseases, and six representatives of ongoing and/or past rare diseases projects financed by the Community Framework Programmes for Research and Technological Development (3). The 27 representatives of the Member States shall be appointed by the Member States. The representative of the European Centre for Disease Prevention and Control (ECDC) shall be appointed by the ECDC. ---|--- (3) | In accordance with Article 3(4) of Decision 2009/872/EC and with a view to selecting these members the Commission published four calls for expression of interest which specified the required qualifications and conditions to become member of the Committee. These calls led to lists of suitable candidates from which, based on the assessment criteria listed in the calls, the Commission hereby appoints the said members, ---|--- HAS DECIDED AS FOLLOWS: Sole Article The experts listed in the Annex to this Decision are appointed as members of the EU Committee on Rare Diseases. Done at Brussels, 27 July 2010. For the Commission John DALLI Member of the Commission * * * (1) OJ L 315, 2.12.2009, p. 18. (2) OJ L 155, 22.6.1999, p. 1; OJ L 271, 9.10.2002, p. 1; OJ L 301, 20.11.2007, p. 3. (3) OJ L 412, 30.12.2006, p. 1. * * * ANNEX List of experts appointed by the Commission as members of the EU Committee on Rare Diseases 1\. Patients’ organisations 1.1. List in alphabetical order of representatives from patients’ organisations Last name | First name | Institute or organisation of affiliation ---|---|--- Dan | Dorica | European Organisation for Rare Diseases Grønnebæk | Torben | European Organisation for Rare Diseases Le Cam | Yann | European Organisation for Rare Diseases Nourissier | Christel | European Organisation for Rare Diseases 1.2. List in alphabetical order of alternates from patients’ organisations Last name | First name | Institute or organisation of affiliation ---|---|--- Geissler | Jan | European Organisation for Rare Diseases Kent | Alastair | European Organisation for Rare Diseases Pizzera-Piantanida | Bianca | European Organisation for Rare Diseases Pogany | Gabor | European Organisation for Rare Diseases 2\. Pharmaceutical industry 2.1. List in alphabetical order of representatives from the pharmaceutical industry Last name | First name | Institute or organisation of affiliation ---|---|--- Hughes-Wilson | Wills | Genzyme Loth | Kevin William | Celgene Parker | Samantha | Orphan Europe Valenta | Barbara | Baxter 2.2. List in alphabetical order of alternates from the pharmaceutical industry Last name | First name | Institute or organisation of affiliation ---|---|--- Fehervary | Andras C. | Novartis Finck | Katia | Shire Human Genetic Therapies Tellier | Zéra | LFB Biomédicaments Zimmermann | Martine | Alexion Europe 3\. Projects in the field of rare diseases financed by programmes of Community action in the field of health 3.1. List in alphabetical order of representatives from ongoing and/or past projects in the field of rare diseases financed by programmes of Community action in the field of health including three members of the pilot European Reference Networks on rare diseases Last name | First name | Institute or organisation of affiliation ---|---|--- Aymé | Ségolène | Orphanet Inserm Donadieu | Jean | Hopital Trousseau Donnai | Dian | European Network of Centres of Expertise in Dysmorphology Fregonese | Laura | CHUV Lausanne Garne | Ester | Hospital Lillebaelt-Kolding Taruscio | Domenica | National Center for Rare Diseases at the Istituto Superiore di Sanità Vives Corrons | Joan Luis | European Network for Rare Congenital Anaemias Wagner | Thomas | European Centres of Reference Network for Cystic Fibrosis Webb | Susan | Hospital de Sant Pau de Barcelona 3.2. List in alphabetical order of alternates from ongoing and/or past projects in the field of rare diseases financed by programmes of Community action in the field of health Last name | First name | Institute or organisation of affiliation ---|---|--- Dubertret | Louis | Fondation Rene Touraine Eleftheriou | Androulla Anastasiou | Thalassemia International Federation Gatta | Gemma | Fondazione IRCCS, Instituto Nazionale dei Tumori Kaminska | Magdalena | European Paediatric Hodgkin Network Nelen | Vera | Provinciaal Instituut voor Hygiene Nguyen | Gérard | Rett Syndrome Europe Vittozzi | Luciano | Centro Nazionale Malattie Rare Weill | Alain | European Haemophilia Consortium Zeidler | Cornelia | Medizinische Hochschule Hannover 4\. Projects in the field of rare diseases financed by the Community Framework Programmes for Research and Technological Development 4.1. List in alphabetical order of representatives from ongoing and/or past projects in the field of rare diseases financed by the Community Framework Programmes for Research and Technological Development Last name | First name | Institute or organisation of affiliation ---|---|--- Blay | Jean-Yves | European Organisation for Research and Treatment of Cancer Bushby | Kate | Institute of Human Genetics, University of Newcastle De Baets | Marc | School for Mental Health and Neuroscience, Maastricht University Hiort | Olaf | Universitätsklinikum Schleswig-Holstein Koutouzov | Sophie | GIS-Institut des Maladies Rares Wagemaker | Gerard | Department of Haematology, Erasmus University Medical Center Rotterdam 4.2. List in alphabetical order of alternates from ongoing and/or past projects in the field of rare diseases financed by the Community Framework Programmes for Research and Technological Development Last name | First name | Institute or organisation of affiliation ---|---|--- Matthijs | Gert | Centre for Human Genetics, University of Leuven Palau | Francesc | Centro de Investigación Biomédica en Red de Enfermedades Raras Picci | Piero | Istituto Ortopedico Rizzoli di Bologna Rieß | Olaf | Institute of Medical Genetics, University of Tübingen Tanner | Stuart | Emeritus professor at University of Sheffield Zambruno | Giovanna | Istituto Dermopatico dell'Immacolata, Roma * * *